Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04890613
Title Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Senhwa Biosciences, Inc.
Indications

ovarian cancer

pancreatic cancer

prostate cancer

breast cancer

fallopian tube cancer

Advanced Solid Tumor

peritoneum cancer

Therapies

CX-5461

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.